- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Good Neighbor pharmacists can vaccinate patients under collaborative-practice agreements
- Senate passes Drug Quality and Security Act
- Facing pharmacy trends for the remainder of the year
NEW YORK — French drug maker Sanofi-Aventis may get a name change soon, according to a published report.
Bloomberg reported that the drug maker had scheduled a vote at its May 6 stockholders meeting to shorten the name to “Sanofi.” The article paraphrased a spokesman as saying that the current name is difficult for people in some countries to pronounce.
The Sanofi-Aventis name came into being following the 2004 acquisition of Aventis by Sanofi-Synthelabo.
Many publications, including Drug Store News, already use “Sanofi” as an abbreviated form of the company’s name.